Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

It's beginning to look a lot like Gutmas!

Congratulations to Vy Wien Lai, whose image was chosen for 1st place in the MRC/MRF 2025 Festive Science Image Competition.

RDM Careers Day 2025: exploring pathways within and beyond academia

The Researcher Association’s annual RDM Careers Day returned on Thursday 20 November 2025, bringing together DPhil students, postdoctoral researchers and research staff from across RDM for a day of reflection, inspiration, and practical advice.

Battle in the Gut at IF Oxford 2025

In October 2025, researchers from the MRC Translational Immune Discovery Unit led activities on researching gut bacteria at Oxford Science + Ideas Festival.

Professor James Chalmers to join the Radcliffe Department of Medicine

We are delighted to announce that Professor James Chalmers has been recruited to the statutory Rhodes Professorship of Experimental Therapeutics and Clinical Pharmacology at the University of Oxford. Professor Chalmers is currently GSK/Asthma and Lung UK Professor of Respiratory Medicine at the University of Dundee.

Study reveals how drug resistance develops early in targeted AML therapy

A new study led by researchers at the MRC Molecular Haematology Unit has shown that resistance to a targeted treatment for acute myeloid leukaemia (AML) can develop much earlier than expected.

Iron supplement absorption preserved in children with HIV and boosted by prebiotics

New research shows that iron from supplements and fortified foods is well-absorbed in children living with virally suppressed HIV, and that administering iron supplements with prebiotics may enhance their effectiveness and improve their safety.

Oxford scientists map the cells that drive Crohn’s disease fistulas

Researchers at the MRC Translational Immune Discovery Unit have identified how rare populations of abnormal cells drive the formation and persistence of fistulas - painful, tunnel-like tracts that develop in around 30% of people with Crohn’s disease - paving the way for targeted treatments.

Oxford scientists capture genome’s structure in unprecedented detail

RDM scientists have achieved the most detailed view yet of how DNA folds and functions inside living cells, revealing the physical structures that control when and how genes are switched on.

Abdullah Khan receives Wellcome Career Development Award

Congratulations are in order for Dr Abdullah (Abs) Khan, who has been awarded a Wellcome Career Development Award for his research on age-related immune dysfunction using human model systems.

DPhil student awarded UKEV MOVE Fellowship to advance heart disease research

Congratulations to RDM DPhil student Waleed Seddiq, who has been awarded a MOVE Fellowship from the UK Society for Extracellular Vesicles (UKEV).

Unravelling T-Cell Recognition: Insights from Immunology and AI

From 29 September to 1 October 2025, researchers from across the world gathered in Oxford for a unique conference and hackathon exploring how advances in artificial intelligence can deepen understanding of T-cell biology.

Congratulations to RDM’s new Professors

Three RDM researchers have been awarded the title of Full Professor in the University’s 2025 Recognition of Distinction exercise.

Professor Ellie Tzima receives Leducq Foundation funding to tackle Peripheral Artery Disease

Professor Ellie Tzima from the Radcliffe Department of Medicine has joined an international team of scientists awarded an $8.5 million grant from the Leducq Foundation to study Peripheral Artery Disease (PAD) and accelerate the development of new therapies.

Oxford University to accelerate type 1 diabetes research and care with £10 million gift

The University of Oxford has announced a gift of £10 million from the Bukhman Foundation to support ground-breaking research into type 1 diabetes (T1D). This generous funding will establish the Bukhman Centre for Research Excellence in Type 1 Diabetes, as well as create new academic posts and scholarships, helping to accelerate progress towards better treatments and ultimately a cure.

Body-in-a-chip approach reveals how immune cells respond to heart injury

Oxford scientists build a connected, ‘multi-organoid’ platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.

Christos Kotanidis wins ESC Young Investigator Award 2025 in Preventive Cardiology

Congratulations to Dr Christos Kotanidis, NIHR-funded Academic Clinical Lecturer in Cardiology, who has been awarded the 2025 ESC Young Investigator Award in Preventive Cardiology at the European Society of Cardiology Congress in Madrid.

Weight loss alone doesn’t ease atrial fibrillation symptoms in older adults, study finds

A clinical trial led by researchers in the University of Oxford’s Radcliffe Department of Medicine and Oxford Population Health, has found that while a structured weight-loss programme helped older adults with atrial fibrillation (AF) shed weight safely and sustainably, it did not improve their heart rhythm symptoms or reduce the need for further treatment.

DPhil sponsorship agreement with medical university and hospital /medical centre in Taiwan

On 28 August, RDM signed a Memorandum of Understanding with the National Defense Medical University and Tri-Service General Hospital in Taiwan which will provide funding for their students who have successfully enrolled on the DPhil in Medical Sciences.

Load More